Tomi Pepper

Combination therapy for Burkitt’s lymphoma dramatically improves cure rates in mice

On: January 5, 2026

🛡️ Verifying that you are not a bot ⏳ Verifying your browser… ✓ Verification Complete This page will redirect in a moment… Read MoreContinue Reading

Cassava Shares Sink on Plans to Stop Alzheimer’s Drug Studies

By: Tomi Pepper

On: November 26, 2024

In: Health & Fitness

(Reuters) -Cassava Sciences said it will stop all trials of its Alzheimer’s disease drug after it failed a late-stage study, sending shares of the drug developer plummeting 83% in early trading on Monday. The experimental treatment, simufilam, has been at the center of scrutiny after a medical professor linked toContinue Reading